92 related articles for article (PubMed ID: 2700914)
1. Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells.
Thompson DP; Carter GL; Cory JG
Cancer Commun; 1989; 1(4):253-60. PubMed ID: 2700914
[TBL] [Abstract][Full Text] [Related]
2. Differential turnover of the subunits of ribonucleotide reductase in synchronized leukemia L1210 cells.
Rubin EH; Cory JG
Cancer Res; 1986 Dec; 46(12 Pt 1):6165-8. PubMed ID: 3536076
[TBL] [Abstract][Full Text] [Related]
3. In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.
Somerville L; Cory AH; Cory JG
In Vivo; 2002; 16(3):175-7. PubMed ID: 12182112
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
Johnson CE; Hughes K; Cory JG
Cancer Commun; 1991; 3(10-11):341-9. PubMed ID: 1760249
[TBL] [Abstract][Full Text] [Related]
6. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
Albert DA; Nodzenski E; Yim G; Kowalski J
J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
Kucera R; Brown CL; Paulus H
J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the mRNA levels for the non-heme iron and effector-binding subunits of ribonucleotide reductase.
Carter GL; Cory JG
Adv Enzyme Regul; 1992; 32():227-40. PubMed ID: 1496919
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
Carter GL; Thompson DP; Cory JG
Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
[TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
13. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
14. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
Cory JG; He AW; Cory AH
Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
[TBL] [Abstract][Full Text] [Related]
15. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
[TBL] [Abstract][Full Text] [Related]
16. A common regulation of genes encoding enzymes of the deoxynucleotide metabolism is lost after neoplastic transformation.
Hengstschläger M; Mudrak I; Wintersberger E; Wawra E
Cell Growth Differ; 1994 Dec; 5(12):1389-94. PubMed ID: 7696188
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
[TBL] [Abstract][Full Text] [Related]
19. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
[TBL] [Abstract][Full Text] [Related]
20. Levels of thymidylate synthetase during normal culture growth of L1210 cells.
Cadman E; Heimer R
Cancer Res; 1986 Mar; 46(3):1195-8. PubMed ID: 3943093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
